By
August 20, 2015
____________________________________________________________________________________
“In this country, in 1996 when we saw those antiretrovirals come out, KS
[Kaposi sarcoma] all but disappeared. And we thought that was the end
of KS. Well, not so fast,” said Toby Maurer, M.D., University of
California, San Francisco professor of clinical dermatology at an HIV
grand rounds presentation at San Francisco General Hospital.
Kaposi’s
sarcoma skin lesions
(Photo: National Cancer Institute)
|
Maurer warns that steroids, such as prednisone, can trigger the emergence of KS skin-lesions in people who are infected with HHV-8 but have never shown symptoms of KS before. “I can’t tell you how many times a week I see KS being turned on by prednisone. And not only am I seeing this in the HIV-infected group, but in the gay HIV-negative group in San Francisco. I’m probably seeing maybe three or four people a month who are getting KS turned on by steroids.”
Many people—both those with and without HIV—are infected with the herpes virus that is responsible for KS. It is not entirely clear how HHV-8 is transmitted, but it is though that HHV-8 is transmitted orally and/or sexually. It is estimated that between 30% and 60% of HIV-positive and 20-30% of HIV-negative men who have sex with men are infected with HHV-8.
Issuing a warning, Maurer urged other HIV providers to think twice before prescribing steroid medications. “I am not a lover of using prednisone for our patients anymore. Obviously, there are times when you’ve got to use prednisone. But if you don’t need the prednisone, think about it a hundred times.”
Read more articles from BETA, here.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.